Pharmacological modulation of cutaneous reactivity to histamine: a double-blind acute comparative study between cetirizine, terfenadine and astemizole
- PMID: 2565265
- DOI: 10.1177/030006058901700103
Pharmacological modulation of cutaneous reactivity to histamine: a double-blind acute comparative study between cetirizine, terfenadine and astemizole
Abstract
In a double-blind study performed in 81 healthy volunteers, 10 mg cetirizine and 60 mg terfenadine given orally in a single administration significantly inhibited skin reactivity to histamine. Astemizole (10 mg) was completely ineffective. The inhibitory effect of cetirizine was potent and regular whereas 6/28 (21%) volunteers did not respond to terfenadine. The difference observed between cetirizine and terfenadine might be due to differences in the metabolism of the two drugs after administration: terfenadine is rapidly and extensively metabolized whereas cetirizine is directly active without the need for biotransformation and, indeed is poorly metabolized.
Similar articles
-
Inhibition of the cutaneous response to histamine by H1-blocking agents. Quantitative evaluation of microvascular changes in the skin after histamine challenge and a comparison of the effects of a single intake of cetirizine and terfenadine.Skin Pharmacol. 1988;1(3):192-9. Skin Pharmacol. 1988. PMID: 2908486 Clinical Trial.
-
Quantitative time course study of the skin response to histamine and the effect of H1 blockers. A 3-week crossover double-blind comparative trial of cetirizine and terfenadine.Dermatologica. 1989;179(3):129-34. doi: 10.1159/000248338. Dermatologica. 1989. PMID: 2574115 Clinical Trial.
-
Comparison of the central and peripheral effects of cetirizine and terfenadine.Eur J Clin Pharmacol. 1988;35(3):255-9. doi: 10.1007/BF00558262. Eur J Clin Pharmacol. 1988. PMID: 2903059 Clinical Trial.
-
The second-generation antihistamines. What makes them different?Postgrad Med. 1991 May 1;89(6):87-8, 91-4, 99. doi: 10.1080/00325481.1991.11700919. Postgrad Med. 1991. PMID: 1673571 Review.
-
Recent advances in H1-receptor antagonist treatment.J Allergy Clin Immunol. 1990 Dec;86(6 Pt 2):995-9. doi: 10.1016/s0091-6749(05)80242-8. J Allergy Clin Immunol. 1990. PMID: 1979802 Review.
Cited by
-
Cetirizine. An updated review of its pharmacological properties and therapeutic efficacy.Clin Rev Allergy. 1993 Spring;11(1):65-88. doi: 10.1007/BF02802294. Clin Rev Allergy. 1993. PMID: 8319162 Review. No abstract available.
-
Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria.Drugs. 1990 Nov;40(5):762-81. doi: 10.2165/00003495-199040050-00009. Drugs. 1990. PMID: 1981354 Review.
-
Tuberculosis in the 1990s. Issues for primary care physicians.Can Fam Physician. 1995 Jun;41:1030-6. Can Fam Physician. 1995. PMID: 7780315 Free PMC article. Review.
-
Urticaria. Recognition, causes and treatment.Drugs. 1994 Nov;48(5):717-30. doi: 10.2165/00003495-199448050-00006. Drugs. 1994. PMID: 7530629 Review.
-
Counseling the elderly on decision making for the end of life. Practical issues for physicians.Can Fam Physician. 1995 May;41:829-33. Can Fam Physician. 1995. PMID: 7756920 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources